MX9706927A - Antagonistas biciclicos de taquicininas, preparacion de los mismos y su uso en composiciones farmaceuticas. - Google Patents

Antagonistas biciclicos de taquicininas, preparacion de los mismos y su uso en composiciones farmaceuticas.

Info

Publication number
MX9706927A
MX9706927A MX9706927A MX9706927A MX9706927A MX 9706927 A MX9706927 A MX 9706927A MX 9706927 A MX9706927 A MX 9706927A MX 9706927 A MX9706927 A MX 9706927A MX 9706927 A MX9706927 A MX 9706927A
Authority
MX
Mexico
Prior art keywords
bicyclic
preparation
pharmaceutical composition
tachykinins
antagonists
Prior art date
Application number
MX9706927A
Other languages
English (en)
Inventor
Federico Arcamone
Alberto Carlo Maggi
Laura Quartara
Danilo Giannotti
Original Assignee
Menarini Farma Ind
S R L
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=11351134&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX9706927(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Menarini Farma Ind, S R L filed Critical Menarini Farma Ind
Publication of MX9706927A publication Critical patent/MX9706927A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/50—Cyclic peptides containing at least one abnormal peptide link
    • C07K7/54—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
    • C07K7/56—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation not occurring through 2,4-diamino-butanoic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/22—Tachykinins, e.g. Eledoisins, Substance P; Related peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64—Cyclic peptides containing only normal peptide links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • C07K9/006—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence being part of a ring structure

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Pain & Pain Management (AREA)
  • Cardiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Virology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Communicable Diseases (AREA)
  • Rheumatology (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Oncology (AREA)
  • Pulmonology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

Abstract

Esta invencion se relaciona con compuestos novedosos de formula general (I) y con composiciones farmacéuticas que los contienen.
MX9706927A 1995-03-13 1996-03-11 Antagonistas biciclicos de taquicininas, preparacion de los mismos y su uso en composiciones farmaceuticas. MX9706927A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT95FI000044A IT1277835B1 (it) 1995-03-13 1995-03-13 Composti biciclici, loro preparazione ed uso in composizioni farmaceutiche
PCT/EP1996/001028 WO1996028467A1 (en) 1995-03-13 1996-03-11 Bicyclic tachykinins antagonists, preparation thereof and their use in pharmaceutical composition

Publications (1)

Publication Number Publication Date
MX9706927A true MX9706927A (es) 1997-11-29

Family

ID=11351134

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9706927A MX9706927A (es) 1995-03-13 1996-03-11 Antagonistas biciclicos de taquicininas, preparacion de los mismos y su uso en composiciones farmaceuticas.

Country Status (33)

Country Link
US (1) US6150325A (es)
EP (1) EP0815126B1 (es)
JP (1) JP4618821B2 (es)
KR (1) KR100405009B1 (es)
CN (1) CN1189477C (es)
AR (1) AR004476A1 (es)
AT (1) ATE198481T1 (es)
AU (1) AU696528B2 (es)
BG (1) BG63208B1 (es)
BR (1) BR9607348A (es)
CZ (1) CZ287372B6 (es)
DE (1) DE69611438T2 (es)
DK (1) DK0815126T3 (es)
EA (1) EA000697B1 (es)
EE (1) EE03618B1 (es)
ES (1) ES2155187T3 (es)
GE (1) GEP20002271B (es)
GR (1) GR3035676T3 (es)
HR (1) HRP960117B1 (es)
HU (1) HU222051B1 (es)
IL (1) IL117395A (es)
IT (1) IT1277835B1 (es)
MX (1) MX9706927A (es)
NO (1) NO319290B1 (es)
NZ (1) NZ303982A (es)
PL (1) PL184147B1 (es)
PT (1) PT815126E (es)
RO (1) RO118297B1 (es)
SK (1) SK281899B6 (es)
TW (1) TW565572B (es)
UA (1) UA48962C2 (es)
WO (1) WO1996028467A1 (es)
ZA (1) ZA961983B (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6017705A (en) * 1995-03-14 2000-01-25 Ludwig Institute For Cancer Research Isolated nucleic acid molecules which are members of the MAGE-B family and uses thereof
IT1291776B1 (it) * 1997-02-07 1999-01-21 Menarini Ricerche Spa Composti monociclici a quattro residui bifunzionali, aventi azione nk-2 antagonista
IT1304888B1 (it) * 1998-08-05 2001-04-05 Menarini Ricerche Spa Composti monociclici ad azione nk-2 antagonista e formulazioni che licontengono
WO2001095904A1 (en) * 2000-06-12 2001-12-20 University Of Rochester Method of treating symptoms of hormonal variation, including hot flashes, using tachykinin receptor antagonist
EP1297826A1 (en) * 2001-09-27 2003-04-02 Menarini Ricerche S.p.A. Nasal pharmaceutical compositions containing a NK-2 antagonist
ITFI20020239A1 (it) 2002-12-06 2004-06-07 Menarini Ricerche Spa Processo per la preparazione di composti peptidici biciclici.
ITFI20040221A1 (it) 2004-10-27 2005-01-27 Guidotti & C Spa Composizioni farmaceutiche a base di nk2 antagonisti per uso pediatrico
ITRM20120331A1 (it) 2012-07-12 2014-01-13 Guidotti & C Spa Labor Composizioni pediatriche orali liquide contenenti nepadutant.

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1262902B (it) * 1992-04-15 1996-07-22 Menarini Farma Ind Composti triciclici antagonisti delle tachichinine, loro preparazione e loro uso in composizioni farmaceutiche.

Also Published As

Publication number Publication date
CZ287372B6 (en) 2000-11-15
HUP9801835A3 (en) 2000-05-29
PL184147B1 (pl) 2002-09-30
EE03618B1 (et) 2002-02-15
JPH11501643A (ja) 1999-02-09
DE69611438D1 (de) 2001-02-08
US6150325A (en) 2000-11-21
PL322105A1 (en) 1998-01-05
GEP20002271B (en) 2000-10-25
HRP960117B1 (en) 2001-06-30
IL117395A (en) 1999-12-31
EP0815126A1 (en) 1998-01-07
CN1189477C (zh) 2005-02-16
NO319290B1 (no) 2005-07-11
BR9607348A (pt) 1997-12-30
IT1277835B1 (it) 1997-11-12
NO974057D0 (no) 1997-09-03
TW565572B (en) 2003-12-11
AR004476A1 (es) 1998-12-16
GR3035676T3 (en) 2001-06-29
HRP960117A2 (en) 1997-08-31
ITFI950044A1 (it) 1996-09-13
EE9700230A (et) 1998-04-15
EA199700223A1 (ru) 1998-04-30
IL117395A0 (en) 1996-07-23
EA000697B1 (ru) 2000-02-28
RO118297B1 (ro) 2003-04-30
ZA961983B (en) 1997-09-29
BG101849A (en) 1998-04-30
ES2155187T3 (es) 2001-05-01
BG63208B1 (bg) 2001-06-29
DE69611438T2 (de) 2001-06-13
HU222051B1 (hu) 2003-04-28
CZ286297A3 (cs) 1998-02-18
AU696528B2 (en) 1998-09-10
ATE198481T1 (de) 2001-01-15
ITFI950044A0 (it) 1995-03-13
KR100405009B1 (ko) 2004-05-20
DK0815126T3 (da) 2001-05-07
SK121297A3 (en) 1998-02-04
NZ303982A (en) 1998-04-27
UA48962C2 (uk) 2002-09-16
PT815126E (pt) 2001-06-29
EP0815126B1 (en) 2001-01-03
JP4618821B2 (ja) 2011-01-26
KR19980703011A (ko) 1998-09-05
WO1996028467A1 (en) 1996-09-19
CN1183786A (zh) 1998-06-03
AU5105996A (en) 1996-10-02
HUP9801835A2 (hu) 1999-01-28
NO974057L (no) 1997-11-07
SK281899B6 (sk) 2001-09-11

Similar Documents

Publication Publication Date Title
IL150986A0 (en) 1,2,3,4,- tetrahydroisoquinoline derivatives
MXPA03004780A (es) Nuevas sulfamidas.
UA39168C2 (uk) Фторалкоксифенільні похідні піперидину або хінуклідину, що є антагоністами речовини p і фармацевтична композиція на їх основі
BG102172A (en) New stable medicamentous compositions for the preparation of propellant-free aerosols
IL155806A0 (en) Novel benzazepines and related heterocyclic derivatives which are useful as orexin receptor antagonists
MY117274A (en) Polycyclic amine compounds and their enantiomers,their method of preparation and pharmaceutical compositions in which they are present.
PL340412A1 (en) Bicyclic kinase inhibitors
PL358281A1 (en) Novel compounds
TR200101398T2 (tr) Pirolidin türevleri-CCR-3 reseptörü antagonistleri.
DE60205234D1 (de) 1,2,3,4-tetrahydroisochinolin-derivate als urotensin ii rezeptor-antagonisten
MXPA05010137A (es) Derivados de tetrahidroisoquinolil acetamida para usarse como antagonistas del receptor de orexina.
PL366198A1 (en) Novel compounds
IL114599A0 (en) Substituted pyrimidine compounds their preparation and pharmaceutical compositions containing them
IL112622A0 (en) Camptothecin derivatives, their preparation and pharmaceutical compositions containing them
IL160171A0 (en) Depsipeptide derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same
IL117209A0 (en) 1-aryl-2-acylamino-ethane compounds and pharmaceutical compositions containing them
MX9706927A (es) Antagonistas biciclicos de taquicininas, preparacion de los mismos y su uso en composiciones farmaceuticas.
MY120550A (en) Substituted 1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocin-10-ols, processes for preparing them and their use as pharmaceutical compositions.
NO963331L (no) 5-Heteroarylindol-derivater som benzodiazepin-reseptorsete-agonister og antagonister
MY140724A (en) Novel arylethene-sulfonamides
BG102229A (en) Endothelium receptor antagonists
MY118946A (en) Novel intermediates and their use to prepare n, n''- bridged bisindolylmaleimides
MXPA02006250A (es) Derivados de butino diol.
CA2215372A1 (en) Bicyclic tachykinins antagonists, preparation thereof and their use in pharmaceutical composition
MY138502A (en) Novel alkansulfonamides as endothelin antagonists